-
- Posts: 8
- Joined: Mon Sep 05, 2005 4:19 pm
But During manufacturing of the Large scale up batch due to process problem one excepient ratio changed from 0.5% to 1.0%.
During method development we have done the excepient compatibility by spiking the drug in indivdual excepient and found there was no interference of this excepient.
In my view this increase in the ratio will not affect the Analytical method .
Kindly tell me whether i have to revalidate the method or not ?
If yes which parameter i have to revalidate?
Please suggest the web site from where i can get the Clarity on this Issue?
Please give me the Regualtory Expert E mail Address for getting Clarity?
